Researchers examined data on more than 3,400 BP devices used all over the world. A significant majority of them were never clinically validated for accuracy. 

The document, available in full for free, is the result of a collaboration with the Consumer Technology Association.

Researchers found that ICMs helped detect serious arrhythmic events in this patient population.

The world of EP keeps getting busier and busier, and ICMs make it easier for clinicians to keep up. 

The company reported that its deep neural network led to improved sensitivity and fewer unclassified findings. 

“The findings of this study highlight the need for strategies to reduce and manage the burden of false-positive ILR alerts,” the researchers said.

"These findings might imply that not all AFib is worth screening for, and not all screen-detected AFib merits anticoagulation," researchers wrote. 

This issue “has the potential to inhibit lifesaving therapies,” according to a new analysis in the Journal of the American Heart Association.